August 14, 2025Deleted JournalOpen Access

In Silico Study of Xanthine Oxidase Inhibitory Activity of Secondary Metabolites from Purple-Orange Sweet Potato (Ipomoea batatas L.) Leaves

View Full Paper

Ask AI

Bookmark

Authors

RRRuswanto RuswantoUniversitas Tunas Pembangunan MHMiftahul Huda HSHendy SuhendyBandung Institute of Technology

Discussion

Member takes

Implication

Molecular docking reveals cholest-4-en-3-one as a potent xanthine oxidase inhibitor for hyperuricemia treatment, suggesting its therapeutic potential.

Key Points

Cholest-4-en-3-one shows the strongest xanthine oxidase inhibitory activity, suggesting its therapeutic potential against hyperuricemia.
Binding free energy for cholest-4-en-3-one is −10.47 kcal/mol, with an inhibition constant of 20.99 nM, indicating significant potency.
Molecular docking and dynamics simulations over 100 ns confirm structural stability of the cholest-4-en-3-one complex with the enzyme.
Findings imply that cholest-4-en-3-one may become a valuable candidate for hyperuricemia therapy, pending further experimental validation.

Cite This Study

Ruswanto et al. (2025) studied this question.

synapsesocial.com/papers/68af5f19ad7bf08b1eae20c0 https://doi.org/10.21608/bfsa.2025.395464.2601

View Full Paper

Ask AI

Bookmark

Implication

Molecular docking reveals cholest-4-en-3-one as a potent xanthine oxidase inhibitor for hyperuricemia treatment, suggesting its therapeutic potential.

In Silico Study of Xanthine Oxidase Inhibitory Activity of Secondary Metabolites from Purple-Orange Sweet Potato (Ipomoea batatas L.) Leaves

Discussion

Member takes

Implication

Key Points

Cite This Study

In Silico Study of Xanthine Oxidase Inhibitory Activity of Secondary Metabolites from Purple-Orange Sweet Potato (Ipomoea batatas L.) Leaves

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider